Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Obesity (Silver Spring). 2021 Jun;29(6):954–959. doi: 10.1002/oby.23161

Figure 2.

Figure 2.

A simplified overview of the phosphatidylinositol 3-kinase, protein kinase B, mammalian target of rapamycin (PI3K-Akt-mTOR) pathway. The PI3K-Akt-mTOR pathway has been implicated in obesity, diabetes, and cancer risk, make this pathway a useful bridge between population studies and mechanistically based interventions.